COMP <GO>
CON vs LLY // RSI-14 & 200D SMA MOMENTUM
Concentra Group Holdings Parent Inc. (NYSE) VS. Eli Lilly and Company (NYSE) • 15-METRIC TALLY: CON 4
— LLY 11
▲ RSI-14 & 200D SMA MOMENTUM LEADER: LLY
LAST: $40.38 (-2.11%) • MKT CAP: $5.26B
rsi-technicals
65.8
LAST: $1,417.54 (+3.19%) • MKT CAP: $1.33T
rsi-technicals
77.9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CON VS. LLY)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | CON | LLY | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 41.00% | 83.64% | -42.64 | LLY | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 19.70% | 32.36% | -12.66 | LLY | /roic <GO> |
| EV/EBITDA & P/E Valuation | 15.4x | 36.4x | -21.02 | CON | /valuation <GO> |
| Free Cash Flow Yield | 3.75% | 2.30% | +1.45 | CON | /fcf-yield <GO> |
| Operating Margin | 15.40% | 40.21% | -24.81 | LLY | /operating-margins <GO> |
| Net Profit Margin | 7.70% | 31.90% | -24.20 | LLY | /net-margins <GO> |
| Revenue Growth (YoY) | 13.90% | 45.51% | -31.61 | LLY | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.61% | 0.49% | +0.12 | CON | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.53 | 9.29 | -6.76 | LLY | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 9/9 | -2.00 | LLY | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 6.90% | 6.77% | +0.13 | LLY | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum ACTIVE | 65.8 | 77.9 | -12.06 | LLY | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.00 | 0.51 | +0.49 | CON | /macro-sensitivity <GO> |
| Forward P/E Multiple | 26.5x | 26.3x | +0.25 | LLY | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $5.26B | $1.33T | -$1.33T | LLY | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | CON REV | LLY REV | CON GROSS % | LLY GROSS % | CON FCF | LLY FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $2.16B | $65.18B | 44.0% | 83.0% | $197.1M | $16.81B |
| FY 2024 | $1.90B | $45.04B | 44.0% | 81.3% | $210.3M | $8.82B |
| FY 2023 | $1.84B | $34.12B | 44.0% | 79.3% | $151.6M | $4.24B |
| FY 2022 | — | $28.54B | — | 76.8% | — | $7.59B |
| FY 2021 | — | $28.32B | — | 74.2% | — | $7.37B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CON // BETA 1.00
LLY // BETA 0.51